EASL 2024
Expert Picks From EASL 2024
Ashwani K. Singal, MD, MS, highlights four abstracts from EASL Congress 2024.
OCTOBER 30, 2024
Statin Use Not Linked to Decreased Liver Fibrosis in Population-Based Study
Statin use may not be associated with less progression of liver fibrosis in the general population, according to ...
OCTOBER 17, 2024
Survodutide Shows Significant Improvement in MASH and Liver Fibrosis in Phase 2 Trial
Patients taking the glucagon/glucagon-like peptide-1 receptor dual agonist survodutide saw an 83% improvement in ...
JULY 19, 2024
Load more